Pimarane cyclooxygenase 2 (COX-2) inhibitor and its structure-activity relationship

被引：29
|
作者：
Suh, YG
Kim, YH
Park, MH
Choi, YH
Lee, HK
Moon, JY
Min, KH
Shin, DY
Jung, JK
Park, OH
Jeon, RA
Park, HS
Kang, SA
机构：
[1] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea
[2] Chungnam Univ, Coll Pharm, Taejon 305764, South Korea
[3] Univ Ulsan, Coll Med, Seoul 138040, South Korea
[4] Sookmyung Womens Univ, Coll Pharm, Seoul 140742, South Korea
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 04期
关键词：
D O I：
10.1016/S0960-894X(01)00004-X
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The structure-activity relationship and molecular modelings of a novel pimarane COX-2 inhibitor are reported. Particularly, a series of linker extended analogues designed on the basis of these studies exhibited significantly enhanced COX-2 inhibitory activities and selectivities. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：559 / 562
页数：4
相关论文
共 50 条
  • [1] Structure-activity relationship of a series of novel bicyclic pyrazoles as selective cyclooxygenase-2 (COX-2) inhibitors.
    Garvey, DS
    Janero, DR
    Letts, LG
    Martino, AM
    Murty, MG
    Ranatunge, RR
    Richardson, SK
    Schroeder, JD
    Young, DV
    Zemtseva, IS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U218 - U218
  • [2] Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors
    Khanapure, SP
    Garvey, DS
    Young, DV
    Ezawa, M
    Earl, RA
    Gaston, RD
    Fang, XQ
    Murty, M
    Martino, A
    Shumway, M
    Trocha, M
    Marek, P
    Tam, SW
    Janero, DR
    Letts, LG
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (25) : 5484 - 5504
  • [3] Quantitative structure-activity relationship based modeling of substituted indole Schiff bases as inhibitor of COX-2
    Dwivedi, Amrita
    Singh, Ajeet
    Srivastava, A. K.
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2016, 20 : S457 - S462
  • [4] APRICOXIB Cyclooxygenase-2 (COX-2) Inhibitor Oncolytic
    Edelman, Martin J.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 503 - 509
  • [5] Structure-activity relationship of three 18F-labelled COX-2 inhibitors
    Tietz, Ole
    Marshall, Alison
    Wang, Monica
    Sharma, Sai Kiran
    Way, Jenilee D.
    Wuest, Melinda
    Wuest, Frank
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2015, 58 : S54 - S54
  • [6] Pentoxyphilline as a cyclooxygenase (cox-2) inhibitor in experimental sepsis
    Modzelewski, B
    Janiak, A
    MEDICAL SCIENCE MONITOR, 2004, 10 (07): : BR233 - BR237
  • [7] Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships
    Zarghi, Afshin
    Arfaei, Sara
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2011, 10 (04): : 655 - 683
  • [8] Quantitative structure-activity relationship study of orally active cyclooxygenase-2 (COX-2) inhibitors of derivatives of 3-phenoxypyran-4-one
    Shekhawat, Manju
    Singh, P.
    Kumar, R.
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2007, 44 (01): : 50 - 55
  • [9] Molecular modeling of pyridine derivatives for COX-2 inhibitors: quantitative structure-activity relationship study
    Dwivedi, Amrita
    Srivastava, A. K.
    Singh, Ajeet
    MEDICINAL CHEMISTRY RESEARCH, 2014, 23 (04) : 1865 - 1877
  • [10] Cyclooxygenase-2 (COX-2) Activity is Regulated by Proteolysis
    Mancini, Arturo
    He, QingWen
    Di Battista, John A.
    INFLAMMATION RESEARCH, 2005, 54 : S120 - S120
12345